Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
33.10
-0.01 (-0.03%)
At close: Apr 28, 2026, 4:00 PM EDT
33.12
+0.02 (0.06%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Nanobiotix Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 29.64 | -11.61 | 30.06 | - | 0.01 | Upgrade
|
| Other Revenue | 2.95 | 4.42 | 6.15 | 4.78 | 2.64 | Upgrade
|
| Revenue | 32.59 | -7.19 | 36.21 | 4.78 | 2.65 | Upgrade
|
| Revenue Growth (YoY) | - | - | 658.10% | 80.43% | 13.85% | Upgrade
|
| Gross Profit | 32.59 | -7.19 | 36.21 | 4.78 | 2.65 | Upgrade
|
| Selling, General & Admin | 20.36 | 20.53 | 22.05 | 17.86 | 19.43 | Upgrade
|
| Research & Development | 23.12 | 40.54 | 38.4 | 32.64 | 30.38 | Upgrade
|
| Operating Expenses | 43.48 | 61.07 | 60.45 | 50.49 | 49.81 | Upgrade
|
| Operating Income | -10.88 | -68.26 | -24.24 | -45.72 | -47.17 | Upgrade
|
| Interest Expense | -10.4 | -8.09 | -7.98 | -5.84 | -0.67 | Upgrade
|
| Interest & Investment Income | 0.99 | 2.63 | 1.22 | 0.26 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -3.23 | 2.99 | -2.09 | 2.11 | 6.24 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | 0 | 0 | 0 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -23.54 | -70.73 | -33.09 | -49.19 | -41.58 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -4.23 | - | - | Upgrade
|
| Other Unusual Items | -0.42 | 2.7 | -2.26 | -7.84 | -5.41 | Upgrade
|
| Pretax Income | -23.96 | -68.03 | -39.58 | -57.03 | -47 | Upgrade
|
| Income Tax Expense | 0 | 0.1 | 0.12 | 0.01 | 0.01 | Upgrade
|
| Net Income | -23.96 | -68.13 | -39.7 | -57.04 | -47 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.06 | Upgrade
|
| Net Income to Common | -23.96 | -68.13 | -39.7 | -57.04 | -47.06 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 47 | 37 | 35 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 47 | 37 | 35 | 35 | Upgrade
|
| Shares Change (YoY) | 1.17% | 27.99% | 5.96% | 0.34% | 42.43% | Upgrade
|
| EPS (Basic) | -0.50 | -1.44 | -1.08 | -1.64 | -1.35 | Upgrade
|
| EPS (Diluted) | -0.50 | -1.44 | -1.08 | -1.64 | -1.35 | Upgrade
|
| Free Cash Flow | -33.96 | -20.4 | -12.8 | -37.2 | -30.1 | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -0.43 | -0.35 | -1.07 | -0.87 | Upgrade
|
| Gross Margin | 100.00% | - | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -33.39% | - | -66.94% | -957.22% | -1781.83% | Upgrade
|
| Profit Margin | -73.52% | - | -109.65% | -1194.33% | -1777.97% | Upgrade
|
| Free Cash Flow Margin | -104.19% | - | -35.36% | -778.79% | -1137.14% | Upgrade
|
| EBITDA | -10.49 | -67.67 | -22.73 | -44.22 | -45.61 | Upgrade
|
| EBITDA Margin | -32.18% | - | -62.76% | - | - | Upgrade
|
| D&A For EBITDA | 0.39 | 0.59 | 1.51 | 1.5 | 1.56 | Upgrade
|
| EBIT | -10.88 | -68.26 | -24.24 | -45.72 | -47.17 | Upgrade
|
| EBIT Margin | -33.39% | - | -66.94% | - | - | Upgrade
|
| Revenue as Reported | 32.59 | -7.19 | 36.21 | 4.78 | 2.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.